FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rory Conolly

Research Profile

Concepts & Ideas

Chemicals & Drugs

Living Beings

Activities & Behaviors

Computer Simulation

Physiology

Cell Divisions

Procedures

Occupations

Computational Biology

Disorders

Neoplasms

Anatomy

Co-author Network

Publications

TOP 3
Qiang Zhang; Douglas E Kline; Russell S Thomas; Melvin E Andersen; Sudin Bhattacharya; Rory B Conolly; Robert B Crawford; Norbert E Kaminski
All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Yuchao Zhao; In Chio Lou; Rory B Conolly
Computational modeling of signaling pathways mediating cell cycle checkpoint control and apoptotic responses to ionizing radiation-induced DNA damage.
Frederick J Miller; John H Overton; R Julian Preston; Elizabeth A Gross; Julia Kimbell; Rory B Conolly
The fractions of respiratory tract cells at risk in formaldehyde carcinogenesis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rory Conolly (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Qiang Zhang; Douglas E Kline; Russell S Thomas; Melvin E Andersen; Sudin Bhattacharya; Rory B Conolly; Robert B Crawford; Norbert E Kaminski
All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Toxicology and applied pharmacology 2013;268(1):17-26.
2012: Yuchao Zhao; In Chio Lou; Rory B Conolly
Computational modeling of signaling pathways mediating cell cycle checkpoint control and apoptotic responses to ionizing radiation-induced DNA damage.
Dose-response : a publication of International Hormesis Society 2012;10(2):251-73.
2011: Frederick J Miller; John H Overton; R Julian Preston; Elizabeth A Gross; Julia Kimbell; Rory B Conolly
The fractions of respiratory tract cells at risk in formaldehyde carcinogenesis.
Inhalation toxicology 2011;23(12):689-706.
2011: Miyuki Breen; Michael S Breen; Alun L Lloyd; Natsuko Terasaki; Makoto Yamazaki; Rory B Conolly
Mechanistic computational model of steroidogenesis in H295R cells: role of oxysterols and cell proliferation to improve predictability of biochemical response to endocrine active chemical--metyrapone.
Toxicological sciences : an official journal of the Society of Toxicology 2011;123(1):80-93.
2011: Susan P Felter; Jay I Goodman; Wafa A Harrouk; David J Kirkland; Serrine S Lau; G Craig Llewellyn; R Julian Preston; A Robert Schnatter; Rita Schoeny; Angelika Tritscher; Frans van Velsen; Joel P Bercu; P Michael Bolger; Alan R Boobis; Peter M J Bos; Philip Carthew; Rory B Conolly; Nancy G Doerrer; Gary M Williams
A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens.
Critical reviews in toxicology 2011;41(6):507-44.
2011: Thomas Hartung; Makoto Hayashi; Jan G Hengstler; Lisbeth E Knudsen; Thomas B Knudsen; James M McKim; Walter Pfaller; Bas J Blaauboer; Sieto Bosgra; Edward Carney; Joachim Coenen; Rory B Conolly; Emanuela Corsini; Elaine M Faustman; Anthony Gaspari; Sidney Green; A Wallace Hayes; Erwin L Roggen
An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".
ALTEX 2011;28(3):183-209.
2010: Stephen J Godin; Michael J DeVito; Michael F Hughes; DG Ross; Edward J Scollon; James M Starr; R Woodrow Setzer; Rory B Conolly; Rogelio Tornero-Velez
Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model.
Toxicological sciences : an official journal of the Society of Toxicology 2010;115(2):330-43.
2010: Sudin Bhattacharya; Rory B Conolly; Norbert E Kaminski; Russell S Thomas; Melvin Andersen; Qiang Zhang
A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Toxicological sciences : an official journal of the Society of Toxicology 2010;115(1):51-65.
2010: Nicholas S Luke; Reeder Sams; Michael J DeVito; Rory B Conolly; Hisham A El-Masri
Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence.
Toxicological sciences : an official journal of the Society of Toxicology 2010;115(1):253-66.
2010: Qiang Zhang; Sudin Bhattacharya; Melvin Andersen; Rory B Conolly
Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
Journal of toxicology and environmental health. Part B, Critical reviews 2010;13(2-4):253-76.
2010: Michael S Breen; Miyuki Breen; Natsuko Terasaki; Makoto Yamazaki; Rory B Conolly
Computational model of steroidogenesis in human H295R cells to predict biochemical response to endocrine-active chemicals: model development for metyrapone.
Environmental health perspectives 2010;118(2):265-72.
2010: Qiang Zhang; Sudin Bhattacharya; Douglas E Kline; Robert B Crawford; Rory B Conolly; Russell S Thomas; Norbert E Kaminski; Melvin Andersen
Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.
BMC systems biology 2010;4():40.
2009: Gerald T Ankley; David C Bencic; Michael S Breen; Timothy W Collette; Rory B Conolly; Nancy D Denslow; Stephen Wilton Edwards; Drew R Ekman; Natalia Garcia-Reyero; Kathleen M Jensen; James M Lazorchak; Dalma Martinović; David H Miller; Edward J Perkins; Edward F Orlando; Daniel L Villeneuve; Rong-Lin Wang; Karen Watanabe
Endocrine disrupting chemicals in fish: developing exposure indicators and predictive models of effects based on mechanism of action.
Aquatic toxicology (Amsterdam, Netherlands) 2009;92(3):168-78.
2009: Rory B Conolly
Commentary on "Toxicity testing in the 21st century: implications for human health risk assessment" by Krewski et al.
Risk analysis : an official publication of the Society for Risk Analysis 2009;29(4):480-1; discussion 492-7.
2009: Rory B Conolly; Frederick J Miller; Julia Kimbell; Derek Janszen
Formaldehyde risk assessment.
The Annals of occupational hygiene 2009;53(2):181-4; author reply 184-9.
2008: Elaina M Kenyon; Walter T Klimecki; Hisham A el-Masri; Rory B Conolly; Harvey J Clewell; Barbara D Beck
How can biologically-based modeling of arsenic kinetics and dynamics inform the risk assessment process? - A workshop review.
Toxicology and applied pharmacology 2008;232(3):359-68.
2008: Robert Kavlock; Gerald T Ankley; Jerry Blancato; Michael Breen; Rory B Conolly; David J Dix; Keith Houck; Elaine Hubal; Richard Judson; James Rabinowitz; Ann Richard; R Woodrow Setzer; Imran Shah; Daniel Villeneuve; Eric Weber
Computational toxicology--a state of the science mini review.
Toxicological sciences : an official journal of the Society of Toxicology 2008;103(1):14-27.
2008: Yasong Lu; Manupat Lohitnavy; Micaela Reddy; Ornrat Lohitnavy; Elizabeth Eickman; Amanda Ashley; Lisa Gerjevic; Yihua Xu; Rory B Conolly; Raymond S H Yang
Quantitative analysis of liver GST-P foci promoted by a chemical mixture of hexachlorobenzene and PCB 126: implication of size-dependent cellular growth kinetics.
Archives of toxicology 2008;82(2):103-16.
2008: Andy Nong; Yu-Mei Tan; Michael E Krolski; Jiansuo Wang; Curt Lunchick; Rory B Conolly; Harvey J Clewell
Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition.
Journal of toxicology and environmental health. Part A 2008;71(20):1363-81.
2008: MaryJane K Selgrade; Charles G Plopper; M Ian Gilmour; Rory B Conolly; Brenda S P Foos
Assessing the health effects and risks associated with children's inhalation exposures--asthma and allergy.
Journal of toxicology and environmental health. Part A 2008;71(3):196-207.
2007: Kai H Liao; Yu-Mei Tan; Rory B Conolly; Susan J Borghoff; Michael L Gargas; Melvin Andersen; Harvey J Clewell
Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform.
Risk analysis : an official publication of the Society for Risk Analysis 2007;27(6):1535-51.
2007: Michael S Breen; Daniel L Villeneuve; Miyuki Breen; Gerald T Ankley; Rory B Conolly
Mechanistic computational model of ovarian steroidogenesis to predict biochemical responses to endocrine active compounds.
Annals of biomedical engineering 2007;35(6):970-81.
2007: Lorenz R Rhomberg; Karl Baetcke; Jerry Blancato; James Bus; Samuel Cohen; Rory B Conolly; Rakesh Dixit; John Doe; Karen Ekelman; Penelope A Fenner-Crisp; Paul Harvey; Dale Hattis; Abigail Jacobs; David Jacobson-Kram; Tom Lewandowski; Robert Liteplo; Olavi Pelkonen; Jerry Rice; Diana Somers; Angelo Turturro; Webster West; Stephen Olin
Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
Critical reviews in toxicology 2007;37(9):729-837.
2006: Yu-Mei Tan; Kai H Liao; Rory B Conolly; Benjamin C Blount; Ann M Mason; Harvey J Clewell
Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.
Journal of toxicology and environmental health. Part A 2006;69(18):1727-56.
2006: Qiang Zhang; Melvin E Andersen; Rory B Conolly
Binary gene induction and protein expression in individual cells.
Theoretical biology & medical modelling 2006;3():18.
2005: Rory B Conolly; David W Gaylor; Werner K Lutz
Population variability in biological adaptive responses to DNA damage and the shapes of carcinogen dose-response curves.
Toxicology and applied pharmacology 2005;207(2 Suppl):570-5.
2005: Werner K Lutz; David W Gaylor; Rory B Conolly; Roman W Lutz
Nonlinearity and thresholds in dose-response relationships for carcinogenicity due to sampling variation, logarithmic dose scaling, or small differences in individual susceptibility.
Toxicology and applied pharmacology 2005;207(2 Suppl):565-9.
2005: William Slikker; John F Young; Richard A Corley; David C Dorman; Rory B Conolly; Thomas B Knudsen; Brian L Erstad; Richard H Luecke; Elaine M Faustman; Charles Timchalk; Donald R Mattison
Improving predictive modeling in pediatric drug development: pharmacokinetics, pharmacodynamics, and mechanistic modeling.
Annals of the New York Academy of Sciences 2005;1053():505-18.
2005: Melvin Andersen; James E Dennison; Russell S Thomas; Rory B Conolly
New directions in incidence-dose modeling.
Trends in biotechnology 2005;23(3):122-7.
2005: Melvin Andersen; Russell S Thomas; Kevin W Gaido; Rory B Conolly
Dose-response modeling in reproductive toxicology in the systems biology era.
Reproductive toxicology (Elmsford, N.Y.) 2005;19(3):327-37.
2004: William Slikker; Melvin Andersen; Matthew S Bogdanffy; James S Bus; Steven D Cohen; Rory B Conolly; Raymond M David; Nancy G Doerrer; David C Dorman; David W Gaylor; Dale Hattis; John M Rogers; R Woodrow Setzer; James A Swenberg; Kendall Wallace
Dose-dependent transitions in mechanisms of toxicity: case studies.
Toxicology and applied pharmacology 2004;201(3):226-94.
2004: William Slikker; Melvin Andersen; Matthew S Bogdanffy; James S Bus; Steven D Cohen; Rory B Conolly; Raymond M David; Nancy G Doerrer; David C Dorman; David W Gaylor; Dale Hattis; John M Rogers; R Woodrow Setzer; James A Swenberg; Kendall Wallace
Dose-dependent transitions in mechanisms of toxicity.
Toxicology and applied pharmacology 2004;201(3):203-25.
2004: Rory B Conolly; Julia Kimbell; Derek B Janszen; Paul M Schlosser; Darin Kalisak; Julian Preston; Frederick J Miller
Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
Toxicological sciences : an official journal of the Society of Toxicology 2004;82(1):279-96.
2004: Mercedes Casanova; Philip Cole; James J Collins; Rory B Conolly; Elizabeth Delzell; Henry d' A Heck Hd; Robin Leonard; Rick Lewis; Gary M Marsh; M Gerald Ott; Tom Sorahan; Charles W Axten
Re: Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries.
Journal of the National Cancer Institute 2004;96(12):966-7; author reply 967-8.
2004: Rory B Conolly; Werner K Lutz
Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment.
Toxicological sciences : an official journal of the Society of Toxicology 2004;77(1):151-7.
2004: David W Gaylor; Werner K Lutz; Rory B Conolly
Statistical analysis of nonmonotonic dose-response relationships: research design and analysis of nasal cell proliferation in rats exposed to formaldehyde.
Toxicological sciences : an official journal of the Society of Toxicology 2004;77(1):158-64.
2003: Rory B Conolly; Julia Kimbell; Derek B Janszen; Paul M Schlosser; Darin Kalisak; Julian Preston; Frederick J Miller
Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat.
Toxicological sciences : an official journal of the Society of Toxicology 2003;75(2):432-47.
2003: Yu-Mei Tan; Byron E Butterworth; Michael L Gargas; Rory B Conolly
Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation.
Toxicological sciences : an official journal of the Society of Toxicology 2003;75(1):192-200.
2003: Melvin Andersen; Rory B Conolly; David W Gaylor
Thresholds of carcinogenicity in the ED01 study.
Toxicological sciences : an official journal of the Society of Toxicology 2003;74(2):486-7; author reply 487-8.
2003: Paul M Schlosser; Patrick D Lilly; Rory B Conolly; Derek B Janszen; Julia Kimbell
Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.
Risk analysis : an official publication of the Society for Risk Analysis 2003;23(3):473-87.
2003: Ying C Ou; Rory B Conolly; Russell S Thomas; Daniel L Gustafson; Michael E Long; Ivan D Dobrev; Laura S Chubb; Yihua Xu; Smadar A Lapidot; Melvin Andersen; Raymond S H Yang
Stochastic simulation of hepatic preneoplastic foci development for four chlorobenzene congeners in a medium-term bioassay.
Toxicological sciences : an official journal of the Society of Toxicology 2003;73(2):301-14.
2003: Paul S Price; Rory B Conolly; Christine F Chaisson; Elizabeth A Gross; John S Young; Eric T Mathis; Douglas R Tedder
Modeling interindividual variation in physiological factors used in PBPK models of humans.
Critical reviews in toxicology 2003;33(5):469-503.
2002: Rory B Conolly
The use of biologically based modeling in risk assessment.
Toxicology 2002;181-182():275-9.
2002: Linda K Teuschler; James Klaunig; Edward W Carney; Janice Chambers; Rory B Conolly; Chris Gennings; John P Giesy; Richard C Hertzberg; Curtis Klaassen; Ralph L Kodell; Dennis J Paustenbach; Raymond Yang
Support of science-based decisions concerning the evaluation of the toxicology of mixtures: a new beginning.
Regulatory toxicology and pharmacology : RTP 2002;36(1):34-9.
2002: Rory B Conolly; Julia Kimbell; Derek B Janszen; Frederick J Miller
Dose response for formaldehyde-induced cytotoxicity in the human respiratory tract.
Regulatory toxicology and pharmacology : RTP 2002;35(1):32-43.
2001: Julia Kimbell; JH Overton; Ravi P Subramaniam; Paul M Schlosser; Kevin T Morgan; Rory B Conolly; Frederick J Miller
Dosimetry modeling of inhaled formaldehyde: binning nasal flux predictions for quantitative risk assessment.
Toxicological sciences : an official journal of the Society of Toxicology 2001;64(1):111-21.
2001: Ying C Ou; Rory B Conolly; Russell S Thomas; Y Xu; Melvin Andersen; Laura S Chubb; H C Pitot; Raymond S H Yang
A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Cancer research 2001;61(5):1879-89.
2000: Rory B Conolly; Patrick D Lilly; Julia Kimbell
Simulation modeling of the tissue disposition of formaldehyde to predict nasal DNA-protein cross-links in Fischer 344 rats, rhesus monkeys, and humans.
Environmental health perspectives 2000;108 Suppl 5():919-24.
2000: Russell S Thomas; Rory B Conolly; Daniel L Gustafson; Michael E Long; SA Benjamin; Raymond S H Yang
A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.
Toxicology and applied pharmacology 2000;166(2):128-37.
2000: Sean M Hays; Barbara Elswick; G M Blumenthal; F Welsch; Rory B Conolly; Michael L Gargas
Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
Toxicology and applied pharmacology 2000;163(1):67-74.
2000: Jeffrey W Fisher; David C Dorman; MA Medinsky; F Welsch; Rory B Conolly
Analysis of respiratory exchange of methanol in the lung of the monkey using a physiological model.
Toxicological sciences : an official journal of the Society of Toxicology 2000;53(2):185-93.
1999: Melvin Andersen; Rory B Conolly; E M Faustman; Robert Kavlock; Christopher Portier; D M Sheehan; P J Wier; L Ziese
Quantitative mechanistically based dose-response modeling with endocrine-active compounds.
Environmental health perspectives 1999;107 Suppl 4():631-8.
1999: Rory B Conolly; B D Beck; Jay I Goodman
Stimulating research to improve the scientific basis of risk assessment.
Toxicological sciences : an official journal of the Society of Toxicology 1999;49(1):1-4.
1997: Julia Kimbell; Elizabeth A Gross; RB Richardson; Rory B Conolly; Kevin T Morgan
Correlation of regional formaldehyde flux predictions with the distribution of formaldehyde-induced squamous metaplasia in F344 rat nasal passages.
Mutation research 1997;380(1-2):143-54.
1997: N P Page; D V Singh; W Farland; Jay I Goodman; Rory B Conolly; Melvin Andersen; Harvey J Clewell; Clay B Frederick; H Yamasaki; G Lucier
Implementation of EPA Revised Cancer Assessment Guidelines: Incorporation of Mechanistic and Pharmacokinetic Data.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1997;37(1):16-36.
1997: E A Hubal; Paul M Schlosser; Rory B Conolly; Julia Kimbell
Comparison of inhaled formaldehyde dosimetry predictions with DNA-protein cross-link measurements in the rat nasal passages.
Toxicology and applied pharmacology 1997;143(1):47-55.
1997: D A Kramer; Rory B Conolly
Computer simulation of clonal growth cancer models. I. Parameter estimation using an iterative absolute bisection algorithm.
Risk analysis : an official publication of the Society for Risk Analysis 1997;17(1):115-26.
1996: Thomas L Goldsworthy; Rory B Conolly; Ronny Fransson-Steen
Apoptosis and cancer risk assessment.
Mutation research 1996;365(1-3):71-90.
1996: M Casanova; Rory B Conolly
DNA-protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: pharmacokinetics and risk assessment with DPX as dosimeter.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1996;31(1):103-16.
1996: J L Larson; M V Templin; Douglas Wolf; K C Jamison; J Leininger; S Méry; Kevin T Morgan; Brian A Wong; Rory B Conolly; Byron E Butterworth
A 90-day chloroform inhalation study in female and male B6C3F1 mice: implications for cancer risk assessment.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1996;30(1):118-37.
1995: Rory B Conolly; Byron E Butterworth
Biologically based dose response model for hepatic toxicity: a mechanistically based replacement for traditional estimates of noncancer risk.
Toxicology letters 1995;82-83():901-6.
1995: F Welsch; G M Blumenthal; Rory B Conolly
Physiologically based pharmacokinetic models applicable to organogenesis: extrapolation between species and potential use in prenatal toxicity risk assessments.
Toxicology letters 1995;82-83():539-47.
1995: Byron E Butterworth; M V Templin; Susan J Borghoff; Rory B Conolly; Gregory L Kedderis; Douglas Wolf
The role of regenerative cell proliferation in chloroform-induced cancer.
Toxicology letters 1995;82-83():23-6.
1995: Rory B Conolly
Cancer and non-cancer risk assessment: not so different if you consider mechanisms.
Toxicology 1995;102(1-2):179-88.
1995: K K Terry; B A Elswick; F Welsch; Rory B Conolly
Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse.
Toxicology and applied pharmacology 1995;132(1):103-14.
1995: Susan J Borghoff; Michael L Gargas; Melvin Andersen; Rory B Conolly
Development of a mechanism-based dosimetry model for 2,4,4-trimethyl-2-pentanol-induced alpha 2u-globulin nephropathy in male Fischer 344 rats.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1995;25(1):124-37.
1994: Jeffery M Gearhart; G W Jepson; Harvey J Clewell; Melvin Andersen; Rory B Conolly
Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
Environmental health perspectives 1994;102 Suppl 11():51-60.
1994: Gregory L Kedderis; R O McClellan; Rory B Conolly
Pharmacokinetics and cancer risk assessments.
Regulatory toxicology and pharmacology : RTP 1994;19(3):338-40; discussion 341.
1994: Rory B Conolly; Julia Kimbell
Computer simulation of cell growth governed by stochastic processes: application to clonal growth cancer models.
Toxicology and applied pharmacology 1994;124(2):284-95.
1994: Melvin Andersen; J J Mills; TR Fox; Thomas L Goldsworthy; Rory B Conolly; Linda S Birnbaum
Receptor-mediated toxicity and implications for risk assessment.
Progress in clinical and biological research 1994;387():295-310.
1993: Rory B Conolly; M E Andersen
An approach to mechanism-based cancer risk assessment for formaldehyde.
Environmental health perspectives 1993;101 Suppl 6():169-76.
1993: D O Clarke; B A Elswick; F Welsch; Rory B Conolly
Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model.
Toxicology and applied pharmacology 1993;121(2):239-52.
1993: M Kato; J A Popp; Rory B Conolly; Russell C Cattley
Relationship between hepatocyte necrosis, proliferation, and initiation induced by diethylnitrosamine in the male F344 rat.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1993;20(2):155-62.
1993: Barbara D Beck; Rory B Conolly; Michael Dourson; D Guth; D Hattis; C Kimmel; S C Lewis
Improvements in quantitative noncancer risk assessment. Sponsored by the Risk Assessment Specialty Section of the Society of Toxicology.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1993;20(1):1-14.
1992: Melvin Andersen; K Krishnan; Rory B Conolly; R O McClellan
Biologically based modeling in toxicology research.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1992;15():217-27.
1992: B E Butterworth; J A Popp; Rory B Conolly; T L Goldsworthy
Chemically induced cell proliferation in carcinogenesis.
IARC scientific publications 1992;(116):279-305.
1991: Rory B Conolly; Melvin Andersen
Biologically based pharmacodynamic models: tools for toxicological research and risk assessment.
Annual review of pharmacology and toxicology 1991;31():503-23.
1990: Jeffery M Gearhart; G W Jepson; Harvey J Clewell; Melvin Andersen; Rory B Conolly
Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate.
Toxicology and applied pharmacology 1990;106(2):295-310.
1990: R H Reitz; Alan L Mendrala; R A Corley; J F Quast; Michael L Gargas; Melvin Andersen; D A Staats; Rory B Conolly
Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling.
Toxicology and applied pharmacology 1990;105(3):443-59.
1990: R A Corley; Alan L Mendrala; F A Smith; D A Staats; Michael L Gargas; Rory B Conolly; Melvin Andersen; R H Reitz
Development of a physiologically based pharmacokinetic model for chloroform.
Toxicology and applied pharmacology 1990;103(3):512-27.
1988: Rory B Conolly; R H Reitz; Harvey J Clewell; Melvin Andersen
Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesis.
Toxicology letters 1988;43(1-3):189-200.